title: Stroke: LDL and stroke risk—clinical practice or target practice?
authors.affiliation: Department of Neurology, Myongji Hospital, 55 Hwasu-ro 14beon-gil, Deogyang-gu, Goyang-si, Gyeonggi-do 412-826, Korea.
authors.forename: Jong-Ho
authors.initials: JH
authors.lastname: Park
authors.affiliation: Department of Neurosciences, Medical University of South Carolina, 96 Jonathan Lucas Street, CSB 301, MSC 606, Charleston, SC 29425-6160, USA.
authors.forename: Bruce
authors.initials: B
authors.lastname: Ovbiagele
mesh_terms: D008078:Cholesterol, LDL / Q000097:blood; D019983:Guideline Adherence / Q000706:statistics & numerical data*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D002546:Ischemic Attack, Transient / Q000097:blood / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D012042:Registries; D055502:Secondary Prevention / Q000592:standards*; D020521:Stroke / Q000097:blood / Q000188:drug therapy*
chemical_list: D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors